Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Organon & Co (NYSE: OGN) closed at $9.39 in the last session, up 0.32% from day before closing price of $9.36. In other words, the price has increased by $0.32 from its previous closing price. On the day, 3.58 million shares were traded. OGN stock price reached its highest trading level at $9.4 during the session, while it also had its lowest trading level at $9.155.
Ratios:
We take a closer look at OGN’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.08 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 3.71. For the most recent quarter (mrq), Quick Ratio is recorded 1.13 and its Current Ratio is at 1.65. In the meantime, Its Debt-to-Equity ratio is 12.14 whereas as Long-Term Debt/Eq ratio is at 11.98.
On September 06, 2024, JP Morgan Downgraded its rating to Underweight which previously was Neutral and also upped its target price recommendation from $18 to $20.
Goldman Downgraded its Buy to Neutral on November 03, 2023, whereas the target price for the stock was revised from $33 to $16.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 14 ’25 when COX CARRIE SMITH bought 12,469 shares for $8.07 per share. The transaction valued at 100,591 led to the insider holds 12,469 shares of the business.
Falcione Aaron bought 5,500 shares of OGN for $48,235 on May 07 ’25. The Chief Human Resources Officer now owns 62,974 shares after completing the transaction at $8.77 per share. On May 06 ’25, another insider, Weaver Kirke, who serves as the Gen. Counsel & Corp. Secy. of the company, bought 8,045 shares for $9.21 each. As a result, the insider paid 74,054 and bolstered with 52,489 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OGN now has a Market Capitalization of 2441080832 and an Enterprise Value of 10730277888. As of this moment, Organon’s Price-to-Earnings (P/E) ratio for their current fiscal year is 3.49, and their Forward P/E ratio for the next fiscal year is 2.31. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.75. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.39 while its Price-to-Book (P/B) ratio in mrq is 3.33. Its current Enterprise Value per Revenue stands at 1.708 whereas that against EBITDA is 6.398.
Stock Price History:
The Beta on a monthly basis for OGN is 0.56, which has changed by -0.53857493 over the last 52 weeks, in comparison to a change of 0.16461086 over the same period for the S&P500. Over the past 52 weeks, OGN has reached a high of $23.10, while it has fallen to a 52-week low of $8.01. The 50-Day Moving Average of the stock is -3.43%, while the 200-Day Moving Average is calculated to be -27.53%.
Shares Statistics:
According to the various share statistics, OGN traded on average about 4.53M shares per day over the past 3-months and 5822810 shares per day over the past 10 days. A total of 259.96M shares are outstanding, with a floating share count of 259.04M. Insiders hold about 0.36% of the company’s shares, while institutions hold 79.76% stake in the company. Shares short for OGN as of 1753920000 were 15006377 with a Short Ratio of 3.32, compared to 1751241600 on 15917721. Therefore, it implies a Short% of Shares Outstanding of 15006377 and a Short% of Float of 7.6899999999999995.
